Biotech Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial Results July 10, 2025
Biotech First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418 July 9, 2025
Biotech Independent Meta-Analysis Shows SkylineDx’s Merlin CP-GEP Assay Accurately Stratifies Patients for Sentinel Lymph Node Biopsy Selection July 8, 2025
Biotech GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight July 4, 2025
Biotech Pond Technologies Holdings Inc. Announces Filing of 2025 First Quarter Unaudited Condensed Interim Financial Statements and MD&A July 1, 2025
Search
Biotech
July 10, 2025
July 9, 2025
July 8, 2025
July 7, 2025
July 6, 2025
July 5, 2025
July 4, 2025
July 3, 2025
July 2, 2025
July 1, 2025
